A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 clinical trial. The blood cancer treatment has seen successful response rates in 73% of patients, and an application has been submitted to the FDA to bring the drug to market.
Ook interessant voor je
New insights into HIV vaccine revealed by researchers
Although researchers have previously always struggled to develop an efficient HIV vaccine, the results of a first-in-human clinical trial for a new vaccine appear promising. The new vaccine has been developed using a...
10 x gelezen
The Future of Endowed Chairs in Academic Medicine
As the landscape of philanthropy changes following the COVID-19 pandemic, this commentary considers the future of endowed chairs in academic medicine in the light of articles by Thorndyke and colleagues and by Chin-Hong...
2 x gelezen
Lasting Solutions for Advancement of Women of Color
Despite efforts to improve parity in the biomedical workforce, gender bias persists related to equitable pay, promotion, speaking opportunities, journal editorial positions, research funding, and leadership positions...
0 x gelezen
Recente artikelen
De 3 belangrijkste trends voor LinkedIn in 2023
3 weken geleden
Rare cancer drug for young patients approved
3 weken geleden